Treanda Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

A Phase 2 Clinical Trial to Evaluate Zanubrutinib Combined With BR (Bendamustine/Rituximab) Regimen in Subjects With Newly-diagnosed Waldenstr öm's Macroglobulinemia
Condition:   Waldenström's Macroglobulinemia Intervention:   Drug: zanubrutinib,bendamustine,rituximab Sponsors:   Shanghai Changzheng Hospital;   RenJi Hospital;   Huashan Hospital;   Shanghai 6th People's Hospital;   Huadong Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials